{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:27:19Z","timestamp":1763634439972,"version":"3.45.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160199"],"award-info":[{"award-number":["82160199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hainan Province Science and Technology Special Fund","award":["ZDKJ2021038"],"award-info":[{"award-number":["ZDKJ2021038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24830-x","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:24:00Z","timestamp":1763634240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NSC23766 effectively inhibited retinal neovascularization by disrupting the positive feedback loop between Rac1 and VEGFR2"],"prefix":"10.1038","volume":"15","author":[{"given":"Jisen","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gukun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yikeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xionggao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"24830_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","volume":"62","author":"T Chan-Ling","year":"2018","unstructured":"Chan-Ling, T. et al. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res. 62, 77\u2013119 (2018).","journal-title":"Prog Retin Eye Res."},{"key":"24830_CR2","first-page":"147","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein, M., Schmitz-Valckenberg, S. & Chakravarthy, U. Age-Related Macular Degeneration: Rev. Jama 331, 147\u2013157. (2024).","journal-title":"Age-Related Macular Degeneration: Rev. Jama"},{"key":"24830_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","volume":"51","author":"AW Stitt","year":"2016","unstructured":"Stitt, A. W. et al. The progress in Understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 51, 156\u2013186 (2016).","journal-title":"Prog Retin Eye Res."},{"key":"24830_CR4","doi-asserted-by":"crossref","unstructured":"Wallsh, J. O. & Gallemore, R. P. Anti-VEGF-Resistant retinal diseases: A review of the latest treatment options. Cells 10 (2021).","DOI":"10.3390\/cells10051049"},{"key":"24830_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/intimm\/dxaa008","volume":"32","author":"H Naito","year":"2020","unstructured":"Naito, H., Iba, T. & Takakura, N. Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells. Int. Immunol. 32, 295\u2013305 (2020).","journal-title":"Int. Immunol."},{"key":"24830_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12967-023-04225-0","volume":"21","author":"W Bai","year":"2023","unstructured":"Bai, W. et al. Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization. J. Transl Med. 21, 555 (2023).","journal-title":"J. Transl Med."},{"key":"24830_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte, R. S., Chen, D. S. & Ferrara, N. VEGF in signaling and disease: beyond discovery and development. Cell 176, 1248\u20131264 (2019).","journal-title":"Cell"},{"key":"24830_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons, M., Gordon, E. & Claesson-Welsh, L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat. Rev. Mol. Cell. Biol. 17, 611\u2013625 (2016).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"24830_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.phrs.2016.11.022","volume":"115","author":"F Corti","year":"2017","unstructured":"Corti, F. & Simons, M. Modulation of VEGF receptor 2 signaling by protein phosphatases. Pharmacol. Res. 115, 107\u2013123 (2017).","journal-title":"Pharmacol. Res."},{"key":"24830_CR10","doi-asserted-by":"publisher","first-page":"123474","DOI":"10.1016\/j.lfs.2025.123474","volume":"368","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Targeting JAML promotes normalization of tumour blood vessels to antagonize tumour progression via FAK\/SRC and VEGF\/VEGFR2 signalling pathways. Life Sci. 368, 123474 (2025).","journal-title":"Life Sci."},{"key":"24830_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12964-025-02110-5","volume":"23","author":"L Yao","year":"2025","unstructured":"Yao, L. et al. Soluble E-cadherin contributes to inflammation in acute lung injury via VEGF\/VEGFR2 signaling. Cell. Commun. Signal. 23, 113 (2025).","journal-title":"Cell. Commun. Signal."},{"key":"24830_CR12","doi-asserted-by":"crossref","unstructured":"Uemura, A. & Fukushima, Y. Rho GTPases in retinal vascular diseases. Int. J. Mol. Sci. 22 (2021).","DOI":"10.3390\/ijms22073684"},{"key":"24830_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1158\/1535-7163.MCT-13-0164","volume":"12","author":"HK Bid","year":"2013","unstructured":"Bid, H. K. et al. RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol. Cancer Ther. 12, 1925\u20131934 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"24830_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/onc.2016.221","volume":"36","author":"SK Saha","year":"2017","unstructured":"Saha, S. K. et al. KRT19 directly interacts with \u03b2-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene 36, 332\u2013349 (2017).","journal-title":"Oncogene"},{"key":"24830_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.devcel.2017.08.002","volume":"42","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. YAP\/TAZ orchestrate VEGF signaling during developmental angiogenesis. Dev. Cell. 42, 462\u2013478e7 (2017).","journal-title":"Dev. Cell."},{"key":"24830_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1124\/jpet.115.223610","volume":"354","author":"G Marinkovi\u0107","year":"2015","unstructured":"Marinkovi\u0107, G. et al. The Ins and outs of small GTPase Rac1 in the vasculature. J. Pharmacol. Exp. Ther. 354, 91\u2013102 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"24830_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ydbio.2016.02.005","volume":"411","author":"N Nohata","year":"2016","unstructured":"Nohata, N. et al. Temporal-specific roles of Rac1 during vascular development and retinal angiogenesis. Dev. Biol. 411, 183\u2013194 (2016).","journal-title":"Dev. Biol."},{"key":"24830_CR18","doi-asserted-by":"crossref","unstructured":"Zeng, Z. et al. Genome editing VEGFA prevents corneal neovascularization in vivo. Adv. Sci. (Weinh) 11, e2401710 (2024).","DOI":"10.1002\/advs.202401710"},{"key":"24830_CR19","doi-asserted-by":"publisher","first-page":"41749","DOI":"10.18632\/oncotarget.16978","volume":"8","author":"C Prunier","year":"2017","unstructured":"Prunier, C. et al. LIM kinases: Cofilin and beyond. Oncotarget 8, 41749\u201341763 (2017).","journal-title":"Oncotarget"},{"key":"24830_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.18502\/jovr.v15i3.7452","volume":"15","author":"A Lee","year":"2020","unstructured":"Lee, A. et al. Long-term outcomes of treat and extend regimen of anti-vascular endothelial growth factor in neovascular age-related macular degeneration. J. Ophthalmic Vis. Res. 15, 331\u2013340 (2020).","journal-title":"J. Ophthalmic Vis. Res."},{"key":"24830_CR21","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/DDDT.S295223","volume":"15","author":"RM Hussain","year":"2021","unstructured":"Hussain, R. M. et al. Vascular endothelial growth factor antagonists: Promising players in the treatment of neovascular age-related macular degeneration. Drug Des. Devel Ther. 15, 2653\u20132665 (2021).","journal-title":"Drug Des. Devel Ther."},{"key":"24830_CR22","first-page":"1488","volume":"125","author":"PJ Rosenfeld","year":"2018","unstructured":"Rosenfeld, P. J. & Feuer, W. J. Lessons from recent phase III trial failures: Don\u2019t design phase III trials based on retrospective subgroup analyses from phase. II Trials Ophthalmol. 125, 1488\u20131491 (2018).","journal-title":"II Trials Ophthalmol."},{"key":"24830_CR23","doi-asserted-by":"crossref","unstructured":"Puliafito, C. A. & Wykoff, C. C. Looking ahead in retinal disease management: Highlights of the 2019 angiogenesis, exudation and degeneration symposium. Int. J. Retina Vitreous. 5, 22 (2019).","DOI":"10.1186\/s40942-019-0174-y"},{"key":"24830_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2018.01.008","volume":"116","author":"A Acevedo","year":"2018","unstructured":"Acevedo, A. & Gonz\u00e1lez-Billault, C. Crosstalk between Rac1-mediated actin regulation and ROS production. Free Radic Biol. Med. 116, 101\u2013113 (2018).","journal-title":"Free Radic Biol. Med."},{"key":"24830_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.phymed.2018.08.002","volume":"55","author":"M Yousefian","year":"2019","unstructured":"Yousefian, M. et al. The natural phenolic compounds as modulators of NADPH oxidases in hypertension. Phytomedicine 55, 200\u2013213 (2019).","journal-title":"Phytomedicine"},{"key":"24830_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature24998","volume":"552","author":"WJ Polacheck","year":"2017","unstructured":"Polacheck, W. J. et al. A non-canonical Notch complex regulates adherens junctions and vascular barrier function. Nature 552, 258\u2013262 (2017).","journal-title":"Nature"},{"key":"24830_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molcel.2016.10.034","volume":"64","author":"SW Plouffe","year":"2016","unstructured":"Plouffe, S. W. et al. Characterization of Hippo pathway components by gene inactivation. Mol. Cell. 64, 993\u20131008 (2016).","journal-title":"Mol. Cell."},{"key":"24830_CR28","first-page":"485","volume":"244","author":"DAK Kuroiwa","year":"2021","unstructured":"Kuroiwa, D. A. K., Malerbi, F. K. & Regatieri, C. V. S. New. Insights Resistant Diabet. Macular Edema Ophthalmol. 244, 485\u2013494. (2021).","journal-title":"New. Insights Resistant Diabet. Macular Edema Ophthalmol."},{"key":"24830_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12964-025-02131-0","volume":"23","author":"R Huilcaman","year":"2025","unstructured":"Huilcaman, R. et al. Inclusion of \u0391V\u03b23 integrin into extracellular vesicles in a caveolin-1 tyrosine-14- phosphorylation dependent manner and subsequent transfer to recipient melanoma cells promotes migration, invasion and metastasis. Cell. Commun. Signal. 23, 139 (2025).","journal-title":"Cell. Commun. Signal."},{"key":"24830_CR30","doi-asserted-by":"publisher","first-page":"103214","DOI":"10.1016\/j.redox.2024.103214","volume":"73","author":"M Waldeck-Weiermair","year":"2024","unstructured":"Waldeck-Weiermair, M. et al. An essential role for EROS in redox-dependent endothelial signal transduction. Redox Biol. 73, 103214 (2024).","journal-title":"Redox Biol."},{"key":"24830_CR31","doi-asserted-by":"crossref","unstructured":"Matsumura, I. et al. Role of Rac1 in p53-Related proliferation and drug sensitivity in multiple myeloma. Cancers (Basel) 17. (2025).","DOI":"10.3390\/cancers17030461"},{"key":"24830_CR32","doi-asserted-by":"publisher","first-page":"30911","DOI":"10.1074\/jbc.M804537200","volume":"283","author":"EA Klein","year":"2008","unstructured":"Klein, E. A. et al. Joint requirement for Rac and ERK activities underlies the mid-G1 phase induction of Cyclin D1 and S phase entry in both epithelial and mesenchymal cells. J. Biol. Chem. 283, 30911\u201330918 (2008).","journal-title":"J. Biol. Chem."},{"key":"24830_CR33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41374-018-0071-2","volume":"98","author":"K Zhou","year":"2018","unstructured":"Zhou, K. et al. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3. Lab. Invest. 98, 989\u2013998 (2018).","journal-title":"Lab. Invest."},{"key":"24830_CR34","doi-asserted-by":"crossref","unstructured":"Ramshekar, A., Wang, H. & Hartnett, M. E. Regulation of Rac1 activation in choroidal endothelial cells: Insights into mechanisms in Age-Related macular degeneration. Cells 10 (2021).","DOI":"10.3390\/cells10092414"},{"key":"24830_CR35","doi-asserted-by":"publisher","first-page":"113059","DOI":"10.1016\/j.expneurol.2019.113059","volume":"322","author":"F Bu","year":"2019","unstructured":"Bu, F. et al. Activation of endothelial ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and angiogenesis via activating Pak1 in mice. Exp. Neurol. 322, 113059 (2019).","journal-title":"Exp. Neurol."},{"key":"24830_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12975-015-0438-2","volume":"7","author":"Q Alhadidi","year":"2016","unstructured":"Alhadidi, Q., Bin Sayeed, M. S. & Shah, Z. A. Cofilin as a promising therapeutic target for ischemic and hemorrhagic stroke. Transl Stroke Res. 7, 33\u201341 (2016).","journal-title":"Transl Stroke Res."},{"key":"24830_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/ceo.12070","volume":"41","author":"XG Huang","year":"2013","unstructured":"Huang, X. G. et al. Rac1 modulates the vitreous-induced plasticity of mesenchymal movement in retinal pigment epithelial cells. Clin. Exp. Ophthalmol. 41, 779\u2013787 (2013).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"24830_CR38","doi-asserted-by":"publisher","first-page":"18031","DOI":"10.18632\/oncotarget.14949","volume":"8","author":"YJ Lai","year":"2017","unstructured":"Lai, Y. J. et al. Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo. Oncotarget 8, 18031\u201318049 (2017).","journal-title":"Oncotarget"},{"key":"24830_CR39","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1074\/jbc.275.14.10141","volume":"275","author":"K Abe","year":"2000","unstructured":"Abe, K. et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J. Biol. Chem. 275, 10141\u201310149 (2000).","journal-title":"J. Biol. Chem."},{"key":"24830_CR40","doi-asserted-by":"crossref","unstructured":"Davila, J. et al. Rac1 regulates endometrial secretory function to control placental development. PLoS Genet. 11, e1005458 (2015).","DOI":"10.1371\/journal.pgen.1005458"},{"key":"24830_CR41","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1096\/fj.07-096438","volume":"22","author":"W Tan","year":"2008","unstructured":"Tan, W. et al. An essential role for Rac1 in endothelial cell function and vascular development. Faseb j. 22, 1829\u20131838 (2008).","journal-title":"Faseb j."},{"key":"24830_CR42","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1007\/s12035-019-01696-5","volume":"56","author":"G Mohammad","year":"2019","unstructured":"Mohammad, G. et al. Functional regulation of an oxidative stress Mediator, Rac1, in diabetic retinopathy. Mol. Neurobiol. 56, 8643\u20138655 (2019).","journal-title":"Mol. Neurobiol."},{"key":"24830_CR43","doi-asserted-by":"crossref","unstructured":"Daroch, A., Purohit, R. & MDbDMRP A novel molecular descriptor-based computational model to identify drug-miRNA relationships. Int. J. Biol. Macromol. 287, 138580 .(2025)s.","DOI":"10.1016\/j.ijbiomac.2024.138580"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24830-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:24:12Z","timestamp":1763634252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24830-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24830"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24830-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Permission to reproduce material from other sources: No materials reproduced from other sources are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"All experiments involving animals in this study were conducted according to the ethical policies and procedures approved by the Ethics Committee of Hainan Medical University (Protocol number: HYLL-2021-132). The authors confirm that this study is reported in accordance with the ARRIVE guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"40931"}}